000 | 01111 a2200325 4500 | ||
---|---|---|---|
005 | 20250518061030.0 | ||
264 | 0 | _c20200521 | |
008 | 202005s 0 0 eng d | ||
022 | _a2173-5778 | ||
024 | 7 |
_a10.1016/j.ad.2018.05.022 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMonteiro, A F | |
245 | 0 | 0 |
_aAggressive Inferior Eyelid Basal Cell Carcinoma: Advantage of Neoadjuvant Vismodegib. _h[electronic resource] |
260 |
_bActas dermo-sifiliograficas _cDec 2019 |
||
300 |
_a863-865 p. _bdigital |
||
500 | _aPublication Type: Case Reports; Letter | ||
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 |
_aAnilides _xtherapeutic use |
650 | 0 | 4 |
_aCarcinoma, Basal Cell _xdrug therapy |
650 | 0 | 4 |
_aEyelid Neoplasms _xdrug therapy |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aNeoadjuvant Therapy |
650 | 0 | 4 |
_aPyridines _xtherapeutic use |
700 | 1 | _aRato, M | |
700 | 1 | _aTrigo, M | |
700 | 1 | _aMartins, C | |
773 | 0 |
_tActas dermo-sifiliograficas _gvol. 110 _gno. 10 _gp. 863-865 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ad.2018.05.022 _zAvailable from publisher's website |
999 |
_c30106028 _d30106028 |